D-0082-2018 Class III Terminated
FDA drug recall D-0082-2018 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Oct 30, 2017 and is designated Class III. Reason for recall: Marketed without an approved NDA/ANDA: Bottles were released prior to final approval. The recall status is terminated (terminated Feb 12, 2020). Affected quantity: 744 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 22, 2017
- Initiation Date
- Oct 30, 2017
- Termination Date
- Feb 12, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 744 bottles
Product description
Meclizine hydrochloride tablets USP, 12.5 mg, 100 count HDPE bottle, Rx only, Manufactured by: Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-122-06
Reason for recall
Marketed without an approved NDA/ANDA: Bottles were released prior to final approval.
Distribution pattern
Nationwide
Code information
Lot # 17P0430, Exp 05/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0082-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026